Replies to post #404067 on Anavex Life Sciences Corp (AVXL)

[catdaddy]

And some wonder why their posts are totally discounted.

[nidan7500]

scorman1

[ RETT after Excellence Trial providing revenues]
revenues isn't profits or cash flow.. Rett will generate nothing from such a small patient base...probably cost more to produce than returns
Extremely rare
Fewer than 1,000 US cases per year
such is "orphan status"

IMO, this will become part of the RWD-RWE -ANAVEX ORPHAN DRUG TREAMENT WW TSUNAMI Process/Program.

[Steady_T]

The drug prices for the rare diseases can be $200K + a year according to MIssling.

So Rett may be able to generate a significant chunk of revenue. Once AD is approved I would expect the drug price to drop massively.

[Mikesc]

It is estimated that one in 10,000 girls is born with Rett syndrome. This means about 15,000 girls and women in the US and 350,000 worldwide have the disorder.

[sab63090]

Scorman1

I remember something that Missling said, but forgot where I heard it....didn't he say that the approval for RETT (adult and children) was worth about $6 Bil???

Also, isn't there a voucher for $100 mil...that is out there, but needs to see the Excellence Trial result in order to keep it....

Maybe someone else here can take this on?

[rx7171]

TGD has commented that he expects the Rett to price in the $400-600K per patient.
The total US Rett population is about 10,000.
Do the math.